@cookvascular
RT @EricSecemskyMD: 7/We followed this up with a separate analysis in @JACCJournals using more historical CMS data and focusing on paclitax…
7/We followed this up with a separate analysis in @JACCJournals using more historical CMS data and focusing on paclitaxel-coated stents vs bare metal stents. This time we had ~50,000 patients and >4 years of follow-up. Again, no evidence of harm. https
RT @abbybcestoni: This recent #JACC article on “Drug-Eluting Stent Implantation and Long-Term Survival Following Peripheral Artery Revascul…
RT @JACCJournals: Drug-eluting stents are not associated with increased mortality compared with bare metal stents in peripheral arterial in…
RT @JACCJournals: Drug-eluting stents are not associated with increased mortality compared with bare metal stents in peripheral arterial in…
RT @JACCJournals: Drug-eluting stents are not associated with increased mortality compared with bare metal stents in peripheral arterial in…
RT @JACCJournals: Drug-eluting stents are not associated with increased mortality compared with bare metal stents in peripheral arterial in…
Drug-eluting stents are not associated with increased mortality compared with bare metal stents in peripheral arterial interventions. https://t.co/TBwn9M4ExW #JACC #cvPAD https://t.co/ow7AIHmsiG
RT @bretwiechmann: Thanks @EricSecemskyMD for adding more quality data to the #paclitaxel discussion. @SIRspecialists @NCVHonline @Vascular…
RT @bretwiechmann: Thanks @EricSecemskyMD for adding more quality data to the #paclitaxel discussion. @SIRspecialists @NCVHonline @Vascular…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @bretwiechmann: Thanks @EricSecemskyMD for adding more quality data to the #paclitaxel discussion. @SIRspecialists @NCVHonline @Vascular…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @bretwiechmann: Thanks @EricSecemskyMD for adding more quality data to the #paclitaxel discussion. @SIRspecialists @NCVHonline @Vascular…
Thanks @EricSecemskyMD for adding more quality data to the #paclitaxel discussion. @SIRspecialists @NCVHonline @VascularMD @roblookstein @bsc_pi @cookvascular @BDandCo @PhilipsHealth
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
The group has also done a separate analysis of ICD-9 data re: DES use: https://t.co/aLixd3FLoi
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
This is in lne with the #NORSTENT RCT trial. https://t.co/u4dinMYYQE could it be that PCI has very little effect on prognosis whatsoever🤔
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @bsc_pi: Another publication by @EricSecemskyMD “We found no evidence of increased long-term mortality following peripheral artery revas…
Another publication by @EricSecemskyMD “We found no evidence of increased long-term mortality following peripheral artery revascularization with DES compared with BMS among CMS beneficiaries, suggesting the safety of these devices in routine practice” #PAD
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
E Secemsky: Important not to forget about CLI patients in this discussion. More data coming from his group tomorrow. #VLF2019 Preview: https://t.co/aLixd3FLoi
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @HarunKundi: Here is our new @JACCJournals paper that shows similar survival (4 yrs) after peripheral DES and BMS https://t.co/HahZpCjSn4
Here is our new @JACCJournals paper that shows similar survival (4 yrs) after peripheral DES and BMS
Interesting that peripheral DES may not provide benefits seen when used for cardiac vasculature. Awesome job @EricSecemskyMD
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
RT @EricSecemskyMD: Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior stud…
Similar long-term survival after peripheral DES vs BMS. Our new study in @JACCJournals Diff patients than prior study, we examined DES vs BMS using ICD9 codes, median f/u 2 yrs, longest 4 yrs. Similar survival before & after adjustment @VIVAPhysicia